Table 1.

Patient characteristics

	Diabetic subjects n = 67	Controls n = 65	p value
Age (years)	65.6 ± 7.8	65.3 ± 9.6	0.86
Male gender, n (%)	44 (66)	49 (75)	0.22
BMI (kg/m2)	29.6 ± 4.0	27.1 ± 3.8	0.002
Arterial hypertension, n (%)	61 (91)	54 (83)	0.17
Smoking, n (%)	17 (25)	14 (22)	0.60
Peripheral artery disease, n (%)	6 (9)	13 (20)	0.07
Previous MI, n (%)	53 (79)	55 (87)	0.41
Aspirin, n (%)	11 (16)	10 (15)	0.87
Statins, n (%)	58 (87)	59 (91)	0.33
Fibrates, n (%)	1 (1)	0	0.32
Thienopyridine, n (%)	3 (4)	1 (2)	0.32
ACEI, n (%)	65 (97)	51 (78)	0.001
β-blocker, n (%)	61 (91)	58 (89)	0.73

Data are shown as mean ± SD or median (IQR) unless otherwise indicated

BMI body mass index, MI myocardial infarction, ACEI angiotensin converting enzyme inhibitor